UPCNasdaq

Universe Pharmaceuticals INC

Healthcare·Healthcare·Ji'An, China

Universe Pharmaceuticals INC (UPC): 1 pipeline candidate. Updated within the last hour.

6.5/10

BioSniper Score

2-factor signal · derived from public data

Cash RunwayN/A

N/A

Financial Health9.6

D/E 0.23 · 0% dilution

Pipeline MaturityN/A

N/A

Pipeline Breadth3.3

1 candidate

Catalyst MomentumN/A

N/A

Insider SignalN/A

N/A

A transparent, data-derived signal for Universe Pharmaceuticals INCacross cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.

Key Financials

Market Cap

$1.9M

Cash

$33.6B

Quarterly Burn

—

Runway

—

Revenue

—

Pipeline (1 candidate)

DrugPhase
patient examination glove—
·CEO: Mr. Gang Lai

Frequently asked questions

How many drug candidates are in Universe Pharmaceuticals INC's pipeline?

Universe Pharmaceuticals INC (UPC) has 1 pipeline candidate tracked by BioSniper across SEC filings and clinical trial registrations.

What is Universe Pharmaceuticals INC's market capitalization?

Universe Pharmaceuticals INC's market capitalization is approximately $1.9M.

Who is the CEO of Universe Pharmaceuticals INC?

Mr. Gang Lai is the chief executive officer of Universe Pharmaceuticals INC (UPC).

Get the full picture on Universe Pharmaceuticals INC

Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.

Start Free AnalysisBrowse Calendar